Home | Business News | Browse by Publication | B | Biotech Business

GENAERA FILES IND FOR TRODUSQUEMINE (MSI-1436).

Publication: Biotech Business
Publication Date: 01-MAR-08
Format: Online
Delivery: Immediate Online Access

Article Excerpt
Genaera Corporation, Plymouth Meeting, Pa., has announced that the investigational new drug (IND) application submitted to the US Food and Drug Administration (FDA) for trodusquemine (MSI-1436) in type 2 diabetes is now in effect. This application represents the second IND filed by the company in 2007 for MSI- 1436. A previous IND for the treatment of obesity, under which Genaera is currently conducting phase 1 clinical trials, has been in effect since April 2007. MSI-1436...

Access Full Article, Compliments of Goliath

View this article FREE - Now for a Limited Time, try Goliath Business News
Free for 3 Days!



More articles from Biotech Business
CHDI FOUNDATION EVALUATES SIX SAMARITAN ALZHEIMER'S DRUGS., March 01, 2008
CHELSEA THERAPEUTICS INITIATES PHASE II TRIAL OF CH-1504.(Medical cond..., March 01, 2008
FDA ACCEPTS AZX100 IND FOR DERMAL/HYPERTROPHIC SCARRING.(Clinical repo..., March 01, 2008

Looking for additional articles?
Search our database of over 3 million articles.

Looking for more in-depth information on this industry?
Search our complete database of Industry & Market reports by text, subject, publication name or publication date.

About Goliath
Whether you're looking for sales prospects, competitive information, company analysis or best practices in managing your organization, Goliath can help you meet your business needs.

Our extensive business information databases empower business professionals with both the breadth and depth of credible, authoritative information they need to support their business goals. Whether it be strategic planning, sales prospecting, company research or defining management best practices - Goliath is your leading source for accurate information.